|
The aim of using ceramides or pseudoceramides in a cosmetic
formulation is to improve the barrier function, i.e., the
maintenance of the lipid layer in stratum corneum. The reason
why the pseudoceramides improves barrier function in the skin
is mainly due to its physical characteristics to form the
multi-lamellar structure with other components in the emulsion.
In the phase study of pseudoceramides / fatty acid / cholesterol
complex system, their ability to form lamellar structure was
determined. Finally, it was demonstrated that pseudoceramides
had the high ability to form the lamellar structure with emulsifier
and with or without oils. When it was observed under the cross-polarized
microscope, the optical anisotropy of Maltese cross, a typical
configuration of multi-lamellar mesophase texture was shown.
And it was demonstrated that this aggregation structure in
the emulsion was similar to the intercellular lipid bilayer
in the skin.
pseudoceramides with Oil
|
pseudoceramides without Oil
|
The cross-polarized light microscopic photography of a pseudo-Stratum
Corneum emulsion (x 400)

Pseudoceramides, An Oil Core with Multi-Lamellar
Liquid Crystal Layers
When the pseudoceramides with oils was squeezed by force,
the emulsion droplet was destroyed and the oil components
at the core of the droplet leaked out into the water phase.
From this result, we can deduct that the 3D structure of the
pseudoceramides are "an oil core with multi-lamellar
liquid crystal layers".

The squeezing demonstration of pseudoceramides
Pseudoceramides Formula Design
The next table represents the comparison of natural skin system
& pseudoceramides compositions. Because the structure
and composition of pseudoceramides are very similar to those
of natural skin system, the pseudoceramides can contribute
to the barrier recovery of the damaged skin, which suggests
the potential of clinical use of pseudoceramides to the chronic
skin diseases originated from barrier abnormality, such as
atopic dermatitis, dry skin, psoriasis, etc.
| Natural Skin care system |
Pseudoceramides |
1. Sebum production
: FFAs, qualene,waxes, stearic acid ester,
free stearic acids, triglyceride, diglyceride,
monoglyceride [Strauss, T.S. 1979] 2.
NMF(natural moisturizing factor)
: AAs, PCA, lactate
3. Stratum corneum lipids
: ceramide, fatty acid,cholesterol
|
1. Sebum components
: FFA, squalene,waxes, stearic acid ester,
triglyceride, monoglyceride 2.
NMF(natural moisturizing factor)
: AAs, PCA, glycerine, PG etc.
3. Pseudo-stratum corneum lipids
: Pseudoceramide, fatty acid, cholesterol
|
STABILITY TEST The stability
test of the pseudoceramides was performed for four weeks within
a cyclic temperature incubator (C/C, -20), in room temperature,
and at 45. , There was no case of destruction or phase separation
of the pseudoceramides, which demonstrate that the pseudoceramides
was very stable.
After a day |
After 4 weeks at RT |
After 4 weeks at C/C |
After 4 weeks at 45 |
Application of Pseudoceramides into
Drug Delivery System (DDS) The most common formula
for DDS was liposome. However, due to its weak stability,
it is well known that the liposome has the limitation on the
wide application on DDS system.
Pseudoceramides can be used to stabilize the active lypophilic
materials within its oil core. The next figure shows that
the pseudoceramides is very good for the stabilization of
retinol palmitate, which is known as an effective material
for the anti-aging & wrinkle of the skin
1) Target :
How to Stabilize Retinols ? 2)
Solution :
Retinols in MLE
Stabilize it in the oil pool of MLE
 |
 |
Effectiveness of Pseudoceramides in
an In vivo System: Barrier Function Recovery We first
assessed whether or not the pseudoceramides has effects on
the damaged skin by measuring the TEWL changes in the acute
disruption model in comparison with placebo and air exposed
non-treatment skin of the hairless mice. The pseudoceramides
and placebo have nearly the same compositions except pseudo-ceramide
(pseudoceramides) and were prepared with the same method.
The figure below shows main components of the pseudoceramides
and the placebo and the optical texture of the emulsions,
which were prepared by the method reported by our R&D
group previously. 17, 18
(A) Pseudoceramides |
(B) Pseudoceramides -2 |
Cross-polarized
light microscopic photography of
MLE cream (A) and the placebo system (B) (X 400)
|
Next, we used the acute barrier disruption model described
earlier with tape-stripped hairless mice to test the effect
of pseudoceramides on barrier recovery. We measured the TEWL
changes in pseudoceramides -treated mouse skin and compared
them with both placebo-treated skin and air-exposed, non-treated
skin. In a comparison test of pseudoceramides -treated and
non-treated (NT) skin, pseudoceramides -treated skin appeared
to show a faster barrier-function repair rate compared with
the air-exposed NT skin. The same is true of the comparison
of the pseudoceramides -treated skin and the placebo-treated
skin. We concluded only that the lamellar structure increase
the intrinsic barrier function recovery.
 |
| ( A ) |
( B ) |
| The effect of pseudoceramides
on barrier recovery, comparing with air exposed non-treated
(N.T) skin (A : p>0.05) and the placebo system (B :
p>0.05). The p values were calculated by Student’s
t-test. |
Effectiveness of pseudoceramides in
an in vivo system: Histopathological studies Comparison of
Epidermal Cell Thickness It has previously been reported
that an occlusive moisturizer, such as vaseline, could develop
a non-permeable barrier on damaged skin19, 20 and that it
is effective in improving the water-holding capacity.21 However,
it has also been reported that the occlusion with water-impermeable
membranes, which prevents water-loss, could not prevent the
epidermal hyperplasia.22 The degree of epidermal hyperplasia
is correlated with the level and duration of barrier disruption
and likewise, the epidermal mitotic index increases with repeated
disruption, indicating that the hyperplasia could be ascribed
to increased cell proliferation. Thus, the damaged skin19
could be better treated when the TEWL value decreases more
rapidly and the epidermal cell thickness increases less rapidly.
In the acute disruption model, the epidermal cell thickness
changes after 24 hours and 48 hours from barrier function
disruption, and the pseudoceramides treated skin showed the
lowest increase in epidermal cell thickness and the air exposed
non-treated skin showed the highest.
 |
 |
( A )
|
( B ) |
(A) The effect of pseudoceramides
on the epidermal cell thickness 48 hours after barrier
disruption; The relative thicknesses are calculated on
the basis of pseudoceramides treated skin thickness. The
p values are calculated by Student’s t-test.
(B) Skin samples were stained with hematoxylin and eosin
In the biopsy samples in the chronic disruption model,
the pseudoceramides treated skin showed the lowest increase
in epidermal cell thickness and the air exposed non-treated
skin showed the highest (data not shown). To verify these
changes, morphological changes of the SC layers in the
chronic disruption model were examined using the OsO4
staining method with an electron microscope, and its results
are shown in the figure below, where the pseudoceramides
treated skin had the fewest numbers of SC layers, and
the air exposed non-treated skin had the most. |
|
| The electron microscopic view of (A)
pseudoceramides, (B) placebo treated and (C) air exposed
non-treated skin (X 5,000). The samples were stained by
the OsO4 staining.Finally, we examined the structure of
the lamellar multi-layers stained by the RuO4 with an
electron microscope. The result informed us that the structure
played an important role to the barrier function. In the
below figure, the pseudoceramides treated skin showed
an almost normal intercorneocyte lipid multi-layer structure,
whereas placebo treated skin and non-treated skin showed
disordered intercorneocyte lipid structures. From these,
it can be concluded that the pseudoceramides must have
a positive effect on the skin barrier in the |
morphological aspect. Electron microscopic views of lipid lamellar
multi-layers stained with RuO4 (X 60k). The intercorneocyte
lipid lamellar multi-layer structure in (A) pseudoceramides
treated skin shows a well ordered structure (arrowhead), and
non-laminated disorganized intercorneocyte lipid in widened
intercellular space are seen in the (B) placebo treated and
(C) air exposed non-treated skin (asterisk). |